NH MPJE 2025-2026 ME WITH COMPLETE
SOLUTIONS 100% CORRECT (A+)
Pharmacists may serve as a pharmacist-in-charge for no more than - ANSWER 2
pharmacies, provided that one of these pharmacies shall be in an institution requiring
the services of a pharmacist only on a part-time basis.
Whenever a pharmacist-in-charge shall cease performing that function in a pharmacy,
the new pharmacist-in-charge shall, within - ANSWER 3 days, cause to be completed a
written inventory of all controlled substances located in that pharmacy. The record of
that inventory shall be retained in the pharmacy for a minimum of 2 years.
A pharmacist may refill a prescription drug order, including controlled substances listed
in Schedules III, IV and V, without the authorization of the prescribing practitioner,
provided that: - ANSWER (a) A failure to refill the prescription might result in an
interruption of a therapeutic regimen or create patient suffering;
(b) The pharmacist is unable to contact the practitioner due to:
(1) A natural or man-made disaster has occurred which prohibits the pharmacist from
being able to contact the practitioner; or
(2) The practitioner's office being closed without a practitioner on call;
(c) The quantity of prescription drug dispensed does not exceed a 30 day supply for
maintenance medications;
d) The pharmacist informs the patient or the patient's agent at the time of dispensing
that the interim supply shall be final and that authorization by the practitioner shall be
required for future refills;
e) The pharmacist shall inform the prescribing practitioner of the limited emergency
supply, provided to the patient, at the earliest reasonable time; and
The pharmacists exercises professional judgment in refilling the prescription drug order
Patient counseling shall :- ANSWER Be by the pharmacist or pharmacy intern and in
,person, whenever practicable, or by telephone; and
Include appropriate elements of patient counseling, such as the following:
The name and description of the drug;
The dosage form, dose, route of administration, and duration of drug therapy;
c. Intended use of the drug and expected action;
d. Special directions and precautions for preparation, administration and use by the
patient;
e. Common side or adverse effects or interactions and therapeutic contraindications
that may be encountered, including their avoidance, and the action required if they
occur;
f. Techniques for self-monitoring drug therapy;
g. Proper storage;
h. Prescription refill information;
i. Action to be taken in the event of a missed dose; and
j. Pharmacist comments relevant to the individual's drug therapy, including any other
information peculiar to the specific patient or drug.
Pharmacists shall be required to make a reasonable effort to counsel the patient or the
patient's caregiver in person or by telephone when dispensing the first fill of a new
prescription for the following: - ANSWER (1) Prescriptions for patients under the age of
13;
(2) Concentrated medications;
(3) Anticoagulant/antiplatelet medications;
(4) Endocrine medications; and
(5) Anti-infective medications.
,destruction of controlled substances - ANSWER A copy shall be retained at the location
where such destruction occurred for a period of 4 years;
DEA 41 form - ANSWER Used to record the destruction of controlled substances
Notice of Closure - ANSWER (a) Written notice to the board shall be submitted at least
15 days in advance of the date of the intended closure. The notice shall specify the date
of closure and the intended disposition of legend drugs including controlled substances
and all records pertaining thereto.
(b) Notice in writing to the DEA shall be submitted no less than 15 days before the date
of the contemplated closing. Obeying DEA directions with respect to closure
procedures will be mandatory.
(c) At least 5 days prior to the anticipated closing a notice shall be conspicuously posted
at the pharmacy indicating the date of closing and the future location of the prescription
files. This notice shall be posted for a period of at least 30 days unless removed by the
landlord or a new tenant.
DEA 222 form - ANSWER Ordering and transfering CII's
No later than 20 days after a pharmacy closing, the licensee shall: - ANSWER (a) Return
the pharmacy permit to the board;
(b) Notify the board that all signs and symbols indicating the presence of a pharmacy
have been removed;
(c) Notify the board that all labels and blank prescriptions have been destroyed;
(d) Provide written notification to the Board that the DEA license and all blank DEA #222
forms have been returned to the Regional Director of the DEA;
(e) File with the board, a copy of the dated inventory of all controlled substances
transferred including the name and address of the person(s) to whom these drugs and
applicable records were transferred; and
, The institution pharmacy and therapeutics committee shall meet at least twice a year.
The major functions of this committee shall be to establish the written policies and
procedures governing the practice of pharmacy, use of drugs, drug specifications, and
drug distribution.
In the ambulatory patient treatment areas, a medical practitioner may dispense drugs
for the immediate needs of the patient, not in excess of a - ANSWER 72-hour supply,
except that, for Schedule II controlled substances, a maximum of 48-hour supply shall
be allowed, if permitted by the institution. The drug container shall be properly labeled.
Purchasing of drugs, pharmaceuticals, biologicals, intravenous and irrigation fluids
shall be subject to approval of the - ANSWER pharmacist-in-charge with the consent of
the institution's pharmacy and therapeutic committee or comparable committee of its
medical staff.
exempted from the approval and/or control of the pharmacist-in-charge by the
institution's pharmacy and therapeutics committee. - ANSWER Radiopharmaceuticals,
blood products, radiopaque media and medical devices
In all cases, the board shall consider: - ANSWER (1) The nature of the offense;
(2) The purpose of the rule or statute violated;
(3) The licensee's state of mind at the time the offense occurred;
(4) The potential harm to the public health;
(5) The deterrent effect upon other practitioners;
(6) The licensee's willingness to cooperate with the board;
(7) The cost to the board of any necessary hearings on formal charges;
SOLUTIONS 100% CORRECT (A+)
Pharmacists may serve as a pharmacist-in-charge for no more than - ANSWER 2
pharmacies, provided that one of these pharmacies shall be in an institution requiring
the services of a pharmacist only on a part-time basis.
Whenever a pharmacist-in-charge shall cease performing that function in a pharmacy,
the new pharmacist-in-charge shall, within - ANSWER 3 days, cause to be completed a
written inventory of all controlled substances located in that pharmacy. The record of
that inventory shall be retained in the pharmacy for a minimum of 2 years.
A pharmacist may refill a prescription drug order, including controlled substances listed
in Schedules III, IV and V, without the authorization of the prescribing practitioner,
provided that: - ANSWER (a) A failure to refill the prescription might result in an
interruption of a therapeutic regimen or create patient suffering;
(b) The pharmacist is unable to contact the practitioner due to:
(1) A natural or man-made disaster has occurred which prohibits the pharmacist from
being able to contact the practitioner; or
(2) The practitioner's office being closed without a practitioner on call;
(c) The quantity of prescription drug dispensed does not exceed a 30 day supply for
maintenance medications;
d) The pharmacist informs the patient or the patient's agent at the time of dispensing
that the interim supply shall be final and that authorization by the practitioner shall be
required for future refills;
e) The pharmacist shall inform the prescribing practitioner of the limited emergency
supply, provided to the patient, at the earliest reasonable time; and
The pharmacists exercises professional judgment in refilling the prescription drug order
Patient counseling shall :- ANSWER Be by the pharmacist or pharmacy intern and in
,person, whenever practicable, or by telephone; and
Include appropriate elements of patient counseling, such as the following:
The name and description of the drug;
The dosage form, dose, route of administration, and duration of drug therapy;
c. Intended use of the drug and expected action;
d. Special directions and precautions for preparation, administration and use by the
patient;
e. Common side or adverse effects or interactions and therapeutic contraindications
that may be encountered, including their avoidance, and the action required if they
occur;
f. Techniques for self-monitoring drug therapy;
g. Proper storage;
h. Prescription refill information;
i. Action to be taken in the event of a missed dose; and
j. Pharmacist comments relevant to the individual's drug therapy, including any other
information peculiar to the specific patient or drug.
Pharmacists shall be required to make a reasonable effort to counsel the patient or the
patient's caregiver in person or by telephone when dispensing the first fill of a new
prescription for the following: - ANSWER (1) Prescriptions for patients under the age of
13;
(2) Concentrated medications;
(3) Anticoagulant/antiplatelet medications;
(4) Endocrine medications; and
(5) Anti-infective medications.
,destruction of controlled substances - ANSWER A copy shall be retained at the location
where such destruction occurred for a period of 4 years;
DEA 41 form - ANSWER Used to record the destruction of controlled substances
Notice of Closure - ANSWER (a) Written notice to the board shall be submitted at least
15 days in advance of the date of the intended closure. The notice shall specify the date
of closure and the intended disposition of legend drugs including controlled substances
and all records pertaining thereto.
(b) Notice in writing to the DEA shall be submitted no less than 15 days before the date
of the contemplated closing. Obeying DEA directions with respect to closure
procedures will be mandatory.
(c) At least 5 days prior to the anticipated closing a notice shall be conspicuously posted
at the pharmacy indicating the date of closing and the future location of the prescription
files. This notice shall be posted for a period of at least 30 days unless removed by the
landlord or a new tenant.
DEA 222 form - ANSWER Ordering and transfering CII's
No later than 20 days after a pharmacy closing, the licensee shall: - ANSWER (a) Return
the pharmacy permit to the board;
(b) Notify the board that all signs and symbols indicating the presence of a pharmacy
have been removed;
(c) Notify the board that all labels and blank prescriptions have been destroyed;
(d) Provide written notification to the Board that the DEA license and all blank DEA #222
forms have been returned to the Regional Director of the DEA;
(e) File with the board, a copy of the dated inventory of all controlled substances
transferred including the name and address of the person(s) to whom these drugs and
applicable records were transferred; and
, The institution pharmacy and therapeutics committee shall meet at least twice a year.
The major functions of this committee shall be to establish the written policies and
procedures governing the practice of pharmacy, use of drugs, drug specifications, and
drug distribution.
In the ambulatory patient treatment areas, a medical practitioner may dispense drugs
for the immediate needs of the patient, not in excess of a - ANSWER 72-hour supply,
except that, for Schedule II controlled substances, a maximum of 48-hour supply shall
be allowed, if permitted by the institution. The drug container shall be properly labeled.
Purchasing of drugs, pharmaceuticals, biologicals, intravenous and irrigation fluids
shall be subject to approval of the - ANSWER pharmacist-in-charge with the consent of
the institution's pharmacy and therapeutic committee or comparable committee of its
medical staff.
exempted from the approval and/or control of the pharmacist-in-charge by the
institution's pharmacy and therapeutics committee. - ANSWER Radiopharmaceuticals,
blood products, radiopaque media and medical devices
In all cases, the board shall consider: - ANSWER (1) The nature of the offense;
(2) The purpose of the rule or statute violated;
(3) The licensee's state of mind at the time the offense occurred;
(4) The potential harm to the public health;
(5) The deterrent effect upon other practitioners;
(6) The licensee's willingness to cooperate with the board;
(7) The cost to the board of any necessary hearings on formal charges;
